Antiphospholipid antibodies in Turkish children with thrombosis

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 4, 2007, Pages 347-352

  Tavil, Betul ^a   Ozyurek, Emel ^b   Gumruk, Fatma ^a   Cetin, Mualla ^a   Gurgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; FULMINATING PURPURA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TURKEY (REPUBLIC); VEIN THROMBOSIS;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PURPURA, SCHOENLEIN-HENOCH; RISK FACTORS; TURKEY; VENOUS THROMBOSIS;

EID: 34247880333     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32809cc95a     Document Type: Article

References (24)

1. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995; 96:291-294.
2. Gurgey A, Aslan D.Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001; 23:159-164.
3. Cesarman-Maus G, Rios-Luna NP, Deora AB, Huang B, Villa R, Del Carmen Cravioto M, et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood 2006; 107:4375- 4382.
4. Ravelli A, Martini A. Antiphospholipid syndrome. Pediatr Clin North Am 2005; 52:469-491.
5. von Scheven E, Athreya BH, Rose CD, Goldsmith DP, Morton L. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129:339-345.
6. Quintero-Del-Rio AI. Antiphospholipid antibodies in pediatrics. Curr Rheumatol Rep 2002; 4:387-391.
7. Owaidah TM, Qurashi FH, Al Nounou RM, Al Zahrani H, Al Mussa A, Tbakhi AI, et al. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies. Hematology 2003; 8:249-257.
8. Greaves M, Cohen H, MacHin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109:704-715.
9. Gurgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis 2004; 15:657-662.
10. Diz-Kucukkaya R, Hancer VS, Inanc M, Nalcaci M, Pekcelen Y. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome. Lupus 2004; 13:32-35.
11. Uysal Z, Dogu F, Kurekci AE, Culha VK, Deda G, Ekim M, et al. Recurrent arterial thrombosis in a child: primary antiphospholipid antibody syndrome. Pediatr Hematol Oncol 2002; 19:59-66.
12. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette J-C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42:1309-1311.
13. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
15. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7:195-200.
16. Macedo CS, Martinez RS, Riyuzo MC, Bastos HD. Renal arterial thrombosis and the antiphospholipid antibody syndrome: a case report. J Pediatr (Rio J) 2001; 77:517-521.
17. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
18. Journeycake JM, Manco-Johnson MJ. Thrombosis during infancy and childhood: what we know and what we do not know. Hematol Oncol Clin North Am 2004; 18:1315-1338.
19. Colucci M, Binetti BM, Tripodi A, Chantarangkul V, Semeraro N. Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism. Blood 2004; 103:2157-2161.
20. Gattorno M, Falcini F, Ravelli A, Zulian F, Buoncompagni A, Martini G, et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus 2003; 12:449-453.
21. Bick RL, Baker WF. Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 1999; 25:333-346.
22. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-1027.
23. De Veber G, Monagle P, Chan A. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55:1539-1543.
24. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94:500-503.